HIMSSCast: The hurdles of AI in the pharma industry
Pharma first started using artificial intelligence in the clinical and development space, but over the last two years, the industry has expanded its use, according to Sandy Donaldson, cofounder president and chief of strategy of Impiricus, a health technology company that provides an AI-powered engagement platform. Over the last two years, AI has been used […]
From Noise to Value: Ending Content Overload for Physicians
As seen in Medical Expo How Ethical AI Can Transform Clinical Decision-Making and Restore Trust in Healthcare Engagement Physicians today face a paradox: they are surrounded by more medical information than ever, yet often struggle to access the pertinent insights they need, when they need them. From clinical guidelines and journal articles to EHR alerts […]
What banning direct-to-consumer pharma ads would mean for doctors
As seen in Medical Economics When U.S. Health and Human Services Secretary Robert F. Kennedy Jr. signaled support for curbing or ending direct-to-consumer (DTC) prescription drug advertising, and senators introduced a bill to prohibit it, the policy debate suddenly felt very close to the exam room. Our thesis is straightforward: a ban would not quiet pharmaceutical ad promotion so much […]
What the FDA’s DTC drug ad crackdown means for pharma companies
As seen in TechTarget As the FDA and HHS rein in direct-to-consumer drug advertising, new compliance rules and AI-driven monitoring could require some pharma companies to rethink their marketing approach. President Trump signed a memorandum, on Sept. 9, directing HHS, “to ensure transparency and accuracy in direct-to-consumer prescription drug advertising including by increasing the amount of information […]